Application of Next Generation Sequencing Upon the Molecular Genetic Diagnosis of Deafness
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The main objective of this review is to describe the new sequencing technologies called next generation sequencing (NGS) and its utility as a molecular genetic diagnosis tool in a medical field. Sanger method has dominated the genome sequencing industry for the past 30 years since its invention in 1975. It produced first human genome and still remains the gold standard for genome sequencing. However, it cannot meet the needs for enormous genetic data gathering and process because of its relatively long sequencing time and high cost per sample. NGS which parallelise the sequencing process, thereby increasing processing speed at a reduced cost per sample emerged to compensate for the weakness of the previous method. Currently NGS is used in some medical areas and its use is being widened. NGS also plays an important role in a study of genetically heterogenous hearing diseases. NGS is expected to mark a significant milestone in genomic research filed in a near future.
Abstract
The main objective of this review is to describe the new sequencing technologies called next generation sequencing (NGS) and its utility as a molecular genetic diagnosis tool in a medical field. Sanger method has dominated the genome sequencing industry for the past 30 years since its invention in 1975. It produced first human genome and still remains the gold standard for genome sequencing. However, it cannot meet the needs for enormous genetic data gathering and process because of its relatively long sequencing time and high cost per sample. NGS which parallelise the sequencing process, thereby increasing processing speed at a reduced cost per sample emerged to compensate for the weakness of the previous method. Currently NGS is used in some medical areas and its use is being widened. NGS also plays an important role in a study of genetically heterogenous hearing diseases. NGS is expected to mark a significant milestone in genomic research filed in a near future.
참고문헌 (24)
- Sanger F, "The Croonian Lecture, 1975. Nucleotide sequences in DNA", Proc R Soc Lond B Biol Sci, 191, pp.317~333 (1975)
- Hutchison CA 3rd, "DNA sequencing: bench to bedside and beyond", Nucleic Acids Res, 35, pp.6227~6237 (2007)
- Venter JC, "The sequence of the human genome", Science, 291, pp.1304~1351 (2001)
- McPherson JD, "A physical map of the human genome", Nature, 409, pp.934~941 (2001)
- Ware JS, "Next generation sequencing for clinical diagnostics and personalised medicine: implications for the next generation cardiologist", Heart, 98, pp.276~281 (2012)
- Metzker ML, "Sequencing technologies - the next generation", Nat Rev Genet, 11, pp.31~46 (2010)
- Choi M, "Genetic diagnosis by whole exome capture and massively parallel DNA sequencing", Proc Natl Acad Sci U S A, 106, pp.19096~19101 (2009)
- Ding L, "Analysis of next-generation genomic data in cancer: accomplishments and challenges", Hum Mol Genet, 19, pp.188~196 (2010)
- Human Genetics Commission, "Information Gathering Session on the Strategic Priorities for Genetics Research" (2007), Human Genetics Commission
- Burton H, "Heart to Heart: Inherited Cardiovascular Conditions Services - a Needs Assessment and Service Review" (2009), The PHG Foundation
- "Hereditary Hearing Loss Homepage 2012"[URL]
- Nance WE, "The genetics of deafness", Ment Retard Dev Disabil Res Rev, 9, pp.109~119 (2003)
- Brownstein Z, "Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in middle eastern families", Genome Biol, 12, pp.89~ (2011)
- Lin X, "Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities", Hear Res (2012)
- Rehman AU, "Targeted capture and next-generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79", Am J Hum Genet, 86, pp.378~388 (2010)
- Walsh T, "Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82", Am J Hum Genet, 87, pp.90~94 (2010)
- Shearer AE, "Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing", Proc Natl Acad Sci U S A, 107, pp.21104~21109 (2010)
- Pierce SB, "Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome", Am J Hum Genet, 87, pp.282~288 (2010)
- Zheng J, "Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with alpha-tectorin and is mutated in autosomal dominant hearing loss (DFNA4)", Proc Natl Acad Sci U S A, 108, pp.4218~4223 (2011)
- Schraders M, "Next-generation sequencing identifies mutations of SMPX, which encodes the small muscle protein, X-linked, as a cause of progressive hearing impairment", Am J Hum Genet, 88, pp.628~634 (2011)
- Smith RJ, "Sensorineural hearing loss in children", Lancet, 365, pp.879~890 (2005)
- Hilgert N, "Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics?", Mutat Res, 681, pp.189~196 (2009)
- Choi BY, "Efficient molecular genetic diagnosis of enlarged vestibular aqueducts in East Asians", Genet Test Mol Biomarkers, 13, pp.679~687 (2009)
- Park HJ, "Genetic basis of hearing loss associated with enlarged vestibular aqueducts in Koreans", Clin Genet, 67, pp.160~165 (2005)